153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)

K Schmierer; D Baker; T Nawaz; K Allen-Philbey; F Barkhof; J Chataway; R Hooper; B Mihaylova; J Hobart; S Pavitt

doi:10.1136/jnnp-2022-abn2.197

153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)

K Schmierer
, D Baker
, T Nawaz
, K Allen-Philbey
, F Barkhof
, J Chataway
, R Hooper
, B Mihaylova
, J Hobart
, S Pavitt

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1136/jnnp-2022-abn2.197
Publication status	Published - Sept 2022

Access to Document

10.1136/jnnp-2022-abn2.197

Cite this

@conference{4b020b7364da4d38b92a3389350db40b,

title = "153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)",

author = "K Schmierer and D Baker and T Nawaz and K Allen-Philbey and F Barkhof and J Chataway and R Hooper and B Mihaylova and J Hobart and S Pavitt",

year = "2022",

month = sep,

doi = "10.1136/jnnp-2022-abn2.197",

language = "English",

}

TY - CONF

T1 - 153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)

AU - Schmierer, K

AU - Baker, D

AU - Nawaz, T

AU - Allen-Philbey, K

AU - Barkhof, F

AU - Chataway, J

AU - Hooper, R

AU - Mihaylova, B

AU - Hobart, J

AU - Pavitt, S

PY - 2022/9

Y1 - 2022/9

U2 - 10.1136/jnnp-2022-abn2.197

DO - 10.1136/jnnp-2022-abn2.197

M3 - Conference paper (not formally published)

ER -